Mizuho raises Tarsus Pharmaceuticals target price to $102 from $94
TARS•Mizuho raised its target price for Tarsus Pharmaceuticals to $102 from $94.
Related News
Insight Enterprises Q3 sales beat estimates, lifts gross profit growth outlook
NSIT•
CION Investment Q3 net asset value falls 2.7% after deleveraging
CION•
Ovid Therapeutics plans participation in three investor conferences
OVID•
Primoris Services Corporation: Oppenheimer cuts target price to $115 from $135
PRIM•
Franklin Managed Municipal Income Trust repurchases 92% of outstanding remarketed preferred shares
FMN•